(c) 2024 PillSync.com

topiramate 100 MG Oral Tablet

1 INDICATIONS AND USAGE Topiramate is an antiepileptic (AED) agent indicated for: Monotherapy epilepsy: Initial monotherapy in patients ≥ 2 years of age with partial onset or primary generalized tonic-clonic seizures ( 1.1 ) Adjunctive therapy epilepsy: Adjunctive therapy for adults and pediatric patients (2 to 16 years of age) with partial onset seizures or primary generalized tonic-clonic seizures, and in patients ≥2 years of age with seizures associated with Lennox-Gastaut syndrome (LGS) ( 1.2 ) 1.1 Monotherapy Epilepsy Topiramate tablets, USP are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures. Safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials [see Clinical Studies ( 14.1 )] . 1.2 Adjunctive Therapy Epilepsy Topiramate tablets, USP are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with Lennox-Gastaut syndrome [see Clinical Studies ( 14.2 )] .

sun pharmaceutical industries, inc.


3 years ago ROUND YELLOW S 711 topiramate 100 MG Oral Tablet

ROUND YELLOW S 711

3 years ago ROUND YELLOW S 711 topiramate 100 MG Oral Tablet

S 711 ROUND YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING

TOPIRAMATE tablets, USP are available as debossed, film-coated, circular tablets in the following strengths and colors: 25 mg white (coded “S” on one side; “707” on the other) 50 mg yellow (coded “S” on one side; “710” on the other) 100 mg yellow (coded “S” on one side; “711” on the other) 200 mg brown (coded “S” on one side; “712” on the other) They are supplied as follows: 25 mg tablets Bottles of 30’s with Child Resistant Cap…………...NDC 62756-707-83 Bottles of 60’s with Child Resistant Cap…………...NDC 62756-707-86 Bottles of 100’s with Child Resistant Cap …............NDC 62756-707-88 Bottles of 100’s with Non Child Resistant Cap ……NDC 62756-707-08 Bottles of 500’s with Non Child Resistant Cap ……NDC 62756-707-13 Bottles of 1000’s with Non Child Resistant Cap …..NDC 62756-707-18 50 mg tablets Bottles of 30’s with Child Resistant Cap…..............NDC 62756-710-83 Bottles of 60’s with Child Resistant Cap…………..NDC 62756-710-86 Bottles of 100’s with Child Resistant Cap …...........NDC 62756-710-88 Bottles of 100’s with Non Child Resistant Cap …...NDC 62756-710-08 Bottles of 500’s with Non Child Resistant Cap …...NDC 62756-710-13 Bottles of 1000’s with Non Child Resistant Cap ….NDC 62756-710-18 100 mg tablets Bottles of 30’s with Child Resistant Cap…..............NDC 62756-711-83 Bottles of 60’s with Child Resistant Cap…………...NDC 62756-711-86 Bottles of 100’s with Child Resistant Cap …............NDC 62756-711-88 Bottles of 100’s with Non Child Resistant Cap ……NDC 62756-711-08 Bottles of 500’s with Non Child Resistant Cap …....NDC 62756-711-13 Bottles of 1000’s with Non Child Resistant Cap …..NDC 62756-711-18 200 mg tablets Bottles of 30’s with Child Resistant Cap…...............NDC 62756-712-83 Bottles of 60’s with Child Resistant Cap…………...NDC 62756-712-86 Bottles of 100’s with Child Resistant Cap …............NDC 62756-712-88 Bottles of 100’s with Non Child Resistant Cap …....NDC 62756-712-08 Bottles of 500’s with Non Child Resistant Cap …....NDC 62756-712-13 Bottles of 1000’s with Non Child Resistant Cap …..NDC 62756-712-18 Storage and Handling Store

TOPIRAMATE tablets at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight container.


More pills like ROUND S 711

Related Pills

topiramate 50 MG Oral Tablet

Sun Pharmaceutical Industries Limited

topiramate 25 MG Oral Tablet

sun pharmaceutical industries, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site